SteriPack, a global contract design and manufacturing organization (CDMO) for the pharmaceutical and medical device industries, has announced its trading name change to Ensera, signaling a strategic shift in its identity and service offering.

Ensera represents the company’s evolution into a global partner providing industry-leading expertise in medical device design and manufacturing, and final assembly and secondary packing for pharmaceuticals and drug-device combination products. Alongside this transformation, its design consultancies, HS Design and Kinneir Dufort, will now trade under a unified name: Ensera Design.

“Changing our trading name to Ensera reflects our enhanced service offering, global reach and the broader, bolder role we play in today’s healthcare ecosystem,” said Jason Anderson, CEO of Ensera. “From tackling design-to-manufacture gaps to enabling faster, smarter delivery of combination products and medical devices, we’re building a business ready for the future and committed to helping our customers improve patient lives through better health outcomes.”

For more than 30 years, SteriPack has supported the world’s leading pharmaceutical and medical device businesses with cleanroom manufacturing services. But with rising industry demands – including decentralized care, the rapid growth in biologics and biosimilars, greater supply chain resilience and increased focus on patient-centric design – the company recognized the need to evolve.

Ensera connects new and next generation product design with cleanroom contract manufacturing, assembly and packing services, helping innovators move from idea to market-ready product and commercial ramp-up with greater speed and precision.

Its services now include:

• Design and product development
• Design for manufacture
• Device component manufacture
• Manual to automated device assembly
• Cleaning and rinsing of primary components
• Sterile barrier system packing and kitting
• Secondary packing of pharmaceuticals and combination products
• Labeling, serialization and aggregation
• Sterilization management
• Supply chain, cold chain and regulatory support

“Our customers came to us with the same challenges time and time again – shorter, more agile and flexible supply chains, low-to-medium volume requirements often with a high SKU mix, and complex or customized device manufacturing and assembly needs to deliver innovative new standards of care to market,” said Anderson. “Now, with more integrated capabilities, we’re removing these barriers and helping pharma and medical device industry leaders reach point of care providers faster.”

Ensera Design is an international healthcare-focused design consultancy formed through the integration of US-based HS Design and UK-based Kinneir Dufort. Together, they bring decades of complementary, award-winning expertise in user experience, human factors, product development and design-for-manufacture, underpinned by a deep understanding of the quality standards and regulations governing healthcare product provision.

Operating across both sides of the Atlantic, Ensera Design partners with established pharmaceutical, MedTech and consumer health companies and start-ups to deliver safe, high-performance, market-ready devices and digital solutions destined for commercial success – with the added benefit of integrated manufacturing capabilities through the wider Ensera Group.

“Every product we collaborate on with our customers is ultimately about a person,” added Anderson. “That’s why we’ve built a design consultancy that combines deep user insight, technical rigor and manufacturing know-how to bring better healthcare solutions to life.”

With available and expanding capacity across the United States, Europe and Southeast Asia, and ongoing investment in facilities, infrastructure and capabilities, Ensera is positioned to support the next generation of healthcare innovation.

This transformation offers clients deeper collaboration, broader expertise and streamlined access to Ensera’s full suite of design and manufacturing capabilities.

“We’re not just solving design and manufacturing challenges, we’re helping shape the future of healthcare,” said Anderson. “Our new names, Ensera and Ensera Design, reflect our commitment to fresh thinking, exceptional execution and long-term partnership.”

Ensera is a global contract design and manufacturing organization (CDMO) specializing in complex product design, manufacturing and supply chain solutions for pharmaceuticals, drug-device combination products and medical devices. With facilities in the United States, Europe and Southeast Asia, we support leading pharma and MedTech innovators on their route to market, with services including design, manufacturing, final assembly, secondary packing, supply chain management and regulatory support. For more information, visit: www.ensera.com 

Ensera Design is a global healthcare innovation partner formed from the integration of Kinneir Dufort and HS Design. With studios in the UK and US, we specialize in human-centered MedTech, pharmaceutical, and consumer health product design and development. Backed by the Ensera Group, our team delivers safe, effective, market-ready solutions that improve health outcomes, with a commitment to quality, sustainability, and global regulatory standards.